FindTrial
Sign In

Prevalence of Transaminase Elevation in Healthy Infants with Breast Milk Jaundice

Prevalence of Transaminase Elevation in Healthy Infants with Breast Milk Jaundice

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
TCTR
Registry ID
TCTR20190225003
Enrollment
Unknown
Registered
2019-02-25
Start date
2017-10-04
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

neonatal jaundice Breast milk jaundice&#44

Interventions

have normal level of all Liver enzymes (AST&#44
ALT&#44
ALP&#44
GGT) ,have elevated level of one of Liver enzymes (AST&#44
GGT)
Other,Other
Normal liver enzymes,Elevated liver enzymes

Sponsors

Department of Pediatrics, Faculty of Medicine, Chulalongkorn university, Bangkok, Thailand
Lead Sponsor

Eligibility

Sex/Gender
All
Age
7 Days to 1 Years

Inclusion criteria

Inclusion criteria: -Newborn GA ≥ 37 weeks -Breast feeding -Unconjugated hyperbilirubinemia -Well grown -Regular excretion of urine and stool -Visible Jaundice

Exclusion criteria

Exclusion criteria: -Conjugated hyperbilirubinemia -G6PD deficiency -Evidenced of hemolysis eg. Hematoma, blood incompatibility -Hypothyroid -Perinatal infection -Perinatal asphyxia -Preterm newborn -Formula feeding

Design outcomes

Primary

MeasureTime frame
analyze the prevalence of elevated liver enzymes in infants with breast milk jaundice at first time after enrolled percentage—

Secondary

MeasureTime frame
duration to normalization of elevated liver enzymes in breast milk jaundice until normalization of liver enzymes time to normalization—

Countries

Thailand

Contacts

Public ContactPirarat Kotcharit

Department of Pediatrics, Faculty of Medicine, Chulalongkorn university

Pirarat.K@student.chula.ac.th+662-256-4951

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 9, 2026